Addressing the need for cost-effective vaccine manufacturing

05:58 EDT 13 Sep 2019 | Manufacturing Chemist

Despite significant advances in biopharmaceutical manufacturing technologies, the cost of producing vaccines and biologic drugs remains relatively high. The price of these life-changing products, even when available in generic versions, remains out of reach for many people in emerging economies in Asia and Africa, writes Tania Pereira-Chilima, Product Manager, Univercells

Original Article: Addressing the need for cost-effective vaccine manufacturing


More From BioPortfolio on "Addressing the need for cost-effective vaccine manufacturing"

Quick Search

Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...